A5015512536- Substance Abuse Treatment and Outcomes
- Gambling Behavior and Treatments
- Attention Deficit Hyperactivity Disorder
- Mental Health Research Topics
- Psychoanalysis and Psychopathology Research
- Eating Disorders and Behaviors
- Opioid Use Disorder Treatment
- Functional Brain Connectivity Studies
- Schizophrenia research and treatment
- Sleep and related disorders
- Cannabis and Cannabinoid Research
- Health, Medicine and Society
- HIV, Drug Use, Sexual Risk
- Bipolar Disorder and Treatment
- Sleep and Wakefulness Research
- Child and Adolescent Psychosocial and Emotional Development
- Neurotransmitter Receptor Influence on Behavior
- Digital Mental Health Interventions
- Behavioral Health and Interventions
- Pain Management and Opioid Use
- Impact of Technology on Adolescents
- Personality Disorders and Psychopathology
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Prenatal Substance Exposure Effects
- Healthcare Systems and Practices
Centre Hospitalier Universitaire de Bordeaux
2016-2025
Université de Bordeaux
2016-2025
Centre National de la Recherche Scientifique
2016-2025
Centre Hospitalier Charles Perrens
2015-2025
Institut de Neurosciences Cognitives et Intégratives d’Aquitaine
2015-2025
Hôpital Cardiologique du Haut-Lévêque
2021-2024
Victor (Japan)
2005-2023
Galen University
2005-2023
Hôpital Pellegrin
2019-2023
Sommeil, Addiction et Neuropsychiatrie
2019-2023
In most European countries, methadone treatment is provided to only 20-30% of opiate abusers who need due regulations and concerns about safety. To address this in France, all registered medical doctors since 1995 have been allowed prescribe buprenorphine (BUP) without any special education or licensing. This led treating approximately 65,000 patients per year with BUP, ten times more than restrictive policies. French physician compensation mechanisms, pharmacy services, insurance funding...
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) substance use (SUD) patients, ranging from 2 to 83%. A better understanding the possible reasons for this variability and effect change DSM-IV DSM-5 is needed.A two stage international multi-center, cross-sectional study 10 countries, among patients form inpatient outpatient addiction treatment centers alcohol and/or drug patients. total 3558 seeking SUD were screened adult ADHD. subsample...
Abstract Aims To determine comorbidity patterns in treatment‐seeking substance use disorder ( SUD ) patients with and without adult attention deficit hyperactivity ADHD ), an emphasis on subgroups defined by subtype, taking into account differences related to gender primary of abuse. Design Data were obtained from the cross‐sectional I nternational Substance Prevalence IASP study. Setting Forty‐seven centres treatment 10 countries. Participants A total 1205 patients. Measurements Structured...
Abstract Background and aims It is well established that craving increases following exposure to substance‐related ‘cues’, but the role of life‐styles or substance use habits are unique each person remains poorly understood. This study examines association substance‐specific personal cues with in daily life. Design Ecological momentary assessment was used during a 2‐week period. Setting Data were collected French out‐patient addiction treatment centre. Participants A total 132 out‐patients...
Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs). This paper describes the methods and study population of International ADHD Substance Use Disorders Prevalence (IASP) study. Objectives IASP are to determine prevalence adult treatment seeking patients SUD different countries populations, reliability validity Adult Self-report Scale V 1.1 (ASRS) as screening instrument investigate comorbidity...
The study examined the validity of 1848 self-reported uses drugs determined within an Addiction Severity Index interview in comparison with urinalysis results among drug-dependent subjects undergoing treatment outpatient clinics (Aquitaine area, southwest France, 1994-2005). Agreement and kappa statistics were calculated for each substance. Factors associated agreement defined using a multivariate analysis. conditional coefficients excellent all substances assessed. accuracy between...
In France, most cases of opioid use disorder are treated with buprenorphine by general practitioners in private practice. Using reimbursement data a representative sample the French population, Echantillon Généraliste des Bénéficiaires, we investigated mortality during periods when patients were and out treatment cohort 713 new users having mean (SD) follow-up 4.5 (1.5) years. The rate was 0.63 per 100 person-years (95% CI, 0.40–0.85) overall. multivariate Cox regression model, compared...
Little is known about psychoactive substance use in students, apart from tobacco, alcohol, and cannabis. This study investigated the prevalence of overlap between various substances students. cross-sectional was conducted 10 066 students included i-Share cohort January 1, 2015, December 31, 2017. The baseline questionnaire key source information. Psychoactive interest (PSI) were cannabis, cocaine, amphetamines, nitrous oxide, poppers, MDMA. Their patterns categorized as lifetime, past year,...
Abstract Background Medication non‐adherence is a leading cause of treatment failure in psychiatric populations. However, current studies highlight the lack methodological guidance on medication assessments. Ecological Momentary Assessment (EMA), using smartphone‐based evaluations, shows promise for real‐time monitoring everyday settings. Aims This study evaluated EMA's effectiveness assessing adherence patients with schizophrenia, depression, and substance use disorders (SUD), covering...